The presence of these markers in the context of BCR function is unclear, however they have been shown to have involvement in NF-κB signaling [57] and consequently potentially represent novel molecules of interest in BCR signaling or DLBCL therapy response. Here, BCR is linked to diffuse large B-cell lymphoma.